What traditional, complementary, and integrative medicine recommendations exist across osteoporosis clinical practice guidelines? A systematic review and quality assessment.
Clinical practice guideline
Complementary and alternative medicine
Osteoporosis
Skeletal disorder
Systematic review
Journal
Integrative medicine research
ISSN: 2213-4220
Titre abrégé: Integr Med Res
Pays: Netherlands
ID NLM: 101612707
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
25
02
2021
revised:
07
09
2021
accepted:
13
10
2021
entrez:
29
11
2021
pubmed:
30
11
2021
medline:
30
11
2021
Statut:
ppublish
Résumé
Traditional, complementary and integrative medicine (TCIM) is sought by more than 50% of patients with osteoporosis. Despite this, many healthcare providers lack the knowledge to adequately counsel patients on safe and effective TCIM use. The purpose of this study was to determine the quantity and quality of TCIM recommendations in clinical practice guidelines (CPGs) for the treatment and/or management of osteoporosis. MEDLINE, EMBASE and CINAHL databases, in addition to the Guidelines International Network, and the National Center for Complementary and Integrative Health website were searched from 2009-2020. CPGs making TCIM recommendations for the treatment/management of osteoporosis were assessed with the AGREE II instrument. Of 536 unique search results, 27 osteoporosis CPGs made mention of TCIM therapies. From highest to lowest, scaled domain percentages of all eligible CPGs averaged to 92.59% for scope and purpose, 88.79% for clarity in presentation, 55.04% for stakeholder involvement, 47.84% for editorial independence, 46.53% for rigor of development, and 36.96% for applicability. Of the 27 CPGs assessed, 4 CPGs were recommended as is by both appraisers, while 23 CPGs were recommended with modifications. Recommendations pertaining to calcium and vitamin D supplementation and exercise were favorably recommended across nearly all CPGs. In the case of other TCIM interventions, recommendations varied greatly, which may present challenges for CPGs target users due to a lack of consistency. Given the varying quality of osteoporosis CPGs found, those requiring improvement may benefit from their guideline development panel utilizing the AGREE II instrument to inform future updates.
Sections du résumé
BACKGROUND
BACKGROUND
Traditional, complementary and integrative medicine (TCIM) is sought by more than 50% of patients with osteoporosis. Despite this, many healthcare providers lack the knowledge to adequately counsel patients on safe and effective TCIM use. The purpose of this study was to determine the quantity and quality of TCIM recommendations in clinical practice guidelines (CPGs) for the treatment and/or management of osteoporosis.
METHODS
METHODS
MEDLINE, EMBASE and CINAHL databases, in addition to the Guidelines International Network, and the National Center for Complementary and Integrative Health website were searched from 2009-2020. CPGs making TCIM recommendations for the treatment/management of osteoporosis were assessed with the AGREE II instrument.
RESULTS
RESULTS
Of 536 unique search results, 27 osteoporosis CPGs made mention of TCIM therapies. From highest to lowest, scaled domain percentages of all eligible CPGs averaged to 92.59% for scope and purpose, 88.79% for clarity in presentation, 55.04% for stakeholder involvement, 47.84% for editorial independence, 46.53% for rigor of development, and 36.96% for applicability. Of the 27 CPGs assessed, 4 CPGs were recommended as is by both appraisers, while 23 CPGs were recommended with modifications.
CONCLUSIONS
CONCLUSIONS
Recommendations pertaining to calcium and vitamin D supplementation and exercise were favorably recommended across nearly all CPGs. In the case of other TCIM interventions, recommendations varied greatly, which may present challenges for CPGs target users due to a lack of consistency. Given the varying quality of osteoporosis CPGs found, those requiring improvement may benefit from their guideline development panel utilizing the AGREE II instrument to inform future updates.
Identifiants
pubmed: 34840950
doi: 10.1016/j.imr.2021.100803
pii: S2213-4220(21)00090-1
pmc: PMC8605333
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100803Informations de copyright
© 2021 Korea Institute of Oriental Medicine. Published by Elsevier B.V.
Références
P T. 2018 Feb;43(2):92-104
pubmed: 29386866
Rev Bras Reumatol Engl Ed. 2017;57 Suppl 2:497-514
pubmed: 28800970
Osteoporos Sarcopenia. 2017 Mar;3(1):1-7
pubmed: 30775497
Endocr Pract. 2016 Sep 2;22(Suppl 4):1-42
pubmed: 27662240
J Clin Oncol. 2019 Nov 1;37(31):2916-2946
pubmed: 31532726
Rev Bras Reumatol Engl Ed. 2017;57 Suppl 2:452-466
pubmed: 28838768
J Obstet Gynaecol Can. 2014 Sep;36(9):839-840
pubmed: 25222365
Endokrynol Pol. 2017;68(5):604-609
pubmed: 29168548
BMC Musculoskelet Disord. 2002 Aug 12;3:20
pubmed: 12174195
Joint Bone Spine. 2014 Dec;81(6):493-501
pubmed: 25455041
BMJ. 1999 Feb 20;318(7182):527-30
pubmed: 10024268
Curr Drug Targets. 2017;18(9):1051-1068
pubmed: 28325144
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Reumatol Clin (Engl Ed). 2019 Jul - Aug;15(4):188-210
pubmed: 30470636
Osteoporos Int. 2004 Oct;15(10):834-41
pubmed: 15045468
Arch Osteoporos. 2014;9:182
pubmed: 24847682
PLoS One. 2018 Dec 6;13(12):e0208251
pubmed: 30521556
Intern Emerg Med. 2019 Jan;14(1):85-102
pubmed: 29948835
Explore (NY). 2017 Jan - Feb;13(1):53-61
pubmed: 27988241
Iowa Orthop J. 1999;19:43-52
pubmed: 10847516
J Bone Miner Metab. 2014 Jul;32(4):337-50
pubmed: 24818875
BMC Complement Altern Med. 2016 Oct 29;16(1):425
pubmed: 27793133
BMC Med Inform Decis Mak. 2007 Jun 15;7:16
pubmed: 17573961
J Womens Health (Larchmt). 2014 Jul;23(7):563-72
pubmed: 24766381
Maturitas. 2013 Aug;75(4):392-6
pubmed: 23810490
Mayo Clin Proc. 2002 May;77(5):453-68
pubmed: 12004995
Arch Osteoporos. 2019 Mar 15;14(1):39
pubmed: 30877479
Complement Ther Med. 2007 Sep;15(3):217-20
pubmed: 17709067
Chin J Integr Med. 2011 Jan;17(1):52-63
pubmed: 21258898
BMC Complement Altern Med. 2019 Mar 20;19(1):73
pubmed: 30894151
Eur Spine J. 2020 Aug;29(8):1833-1844
pubmed: 32236685
Rev Bras Reumatol. 2012 Aug;52(4):580-93
pubmed: 22885424
BMC Complement Med Ther. 2021 Sep 22;21(1):236
pubmed: 34551759
Acta Reumatol Port. 2018 Jan-Mar;43(1):10-31
pubmed: 29602163
J Altern Complement Med. 2010 May;16(5):579-84
pubmed: 20491514
Joint Bone Spine. 2018 Oct;85(5):519-530
pubmed: 29654947
BMC Complement Altern Med. 2014 Feb 06;14:46
pubmed: 24499316
Osteoporos Int. 2017 May;28(5):1531-1542
pubmed: 28168409
J Clin Endocrinol Metab. 2012 Jun;97(6):1802-22
pubmed: 22675062
Reumatismo. 2016 Jun 23;68(1):1-39
pubmed: 27339372
Ann Intern Med. 2017 Jun 6;166(11):818-839
pubmed: 28492856
Osteoporos Int. 2007 Nov;18(11):1547-56
pubmed: 17603742
Arthritis Rheumatol. 2017 Aug;69(8):1521-1537
pubmed: 28585373
J Clin Endocrinol Metab. 2019 May 1;104(5):1595-1622
pubmed: 30907953
Eur J Rheumatol. 2017 Mar;4(1):46-56
pubmed: 28293453
Pain Pract. 2021 Apr;21(4):454-467
pubmed: 33197300
BMC Complement Altern Med. 2016 May 20;16:134
pubmed: 27206976
Lancet. 2007 Aug 25;370(9588):657-66
pubmed: 17720017
BMC Complement Altern Med. 2017 Mar 23;17(1):166
pubmed: 28335766
Arthritis Care Res (Hoboken). 2017 Aug;69(8):1095-1110
pubmed: 28585410
Clin Rheumatol. 2020 Oct;39(10):2861-2873
pubmed: 32385761
Hong Kong Med J. 2013 Apr;19 Suppl 2:1-40
pubmed: 23535738
Ann Saudi Med. 2015 Jan-Feb;35(1):1-12
pubmed: 26142931
Arch Osteoporos. 2016;11:6
pubmed: 26759266
Complement Ther Med. 2021 Jan;56:102595
pubmed: 33197670